Cargando…

Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis

BACKGROUND: The most common cause of death of patients with idiopathic pulmonary fibrosis (IPF) has been reported to be the lung disease itself and mortality from IPF appears to be increasing. However, the causes of death in patients with IPF taking into account differences between genders and smoki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kärkkäinen, Miia, Nurmi, Hanna, Kettunen, Hannu-Pekka, Selander, Tuomas, Purokivi, Minna, Kaarteenaho, Riitta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948790/ https://www.ncbi.nlm.nih.gov/pubmed/29751748 http://dx.doi.org/10.1186/s12890-018-0642-4

Ejemplares similares

Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2017)

Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2019)

Several specific high-resolution computed tomography patterns correlate with survival in patients with idiopathic pulmonary fibrosis
por: Mononen, Minna E., et al.
Publicado: (2021)

Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?
por: Nurmi, Hanna M., et al.
Publicado: (2017)

Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes
por: Nurmi, Hanna M., et al.
Publicado: (2016)

Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases
por: Mononen, Minna, et al.
Publicado: (2022)

Characteristics of idiopathic pulmonary fibrosis -associated cough. a case-control study
por: Saari, Eeva, et al.
Publicado: (2023)

Decline in Mast Cell Density During Diffuse Alveolar Damage in Idiopathic Pulmonary Fibrosis
por: Salonen, Johanna, et al.
Publicado: (2021)

National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care
por: Salonen, Johanna, et al.
Publicado: (2022)

Are physicians in primary health care able to recognize pulmonary fibrosis?
por: Purokivi, Minna, et al.
Publicado: (2017)

Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Inflammatory myositis-associated interstitial lung disease can be distinguished from that associated with other connective tissue diseases
por: Nurmi, Hanna M., et al.
Publicado: (2023)

The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta
Publicado: (2013)

Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetings
por: Salonen, Johanna, et al.
Publicado: (2023)

Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta, et al.
Publicado: (2015)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

NHLRC2 expression is increased in idiopathic pulmonary fibrosis
por: Kreus, Mervi, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
por: Kaunisto, Jaana, et al.
Publicado: (2013)

The challenges in classifying rheumatoid arthritis-associated interstitial lung disease
por: Nurmi, Hanna, et al.
Publicado: (2020)

Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma
por: Kreus, Mervi, et al.
Publicado: (2021)

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
por: Pesonen, Ida, et al.
Publicado: (2018)

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
por: Hollmén, Maria, et al.
Publicado: (2023)

Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis
por: Kaunisto, Jaana, et al.
Publicado: (2015)

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis
por: Lehtonen, Siri T., et al.
Publicado: (2016)

Cough-provocation tests with hypertonic aerosols
por: Koskela, Heikki O., et al.
Publicado: (2020)

Pet ownership supports quality of life in home‐dwelling people with Alzheimer's disease
por: Välimäki, Tarja, et al.
Publicado: (2022)

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
por: Seppälä, Severi, et al.
Publicado: (2020)

Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease
por: Salonen, Johanna, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics
por: Partanen, Juulia J., et al.
Publicado: (2022)

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry
por: Case, Amy Hajari, et al.
Publicado: (2020)

Noninterventional follow‐up vs fluid bolus in RESPONSE to oliguria—The RESPONSE trial protocol and statistical analysis plan
por: Inkinen, Nina, et al.
Publicado: (2020)

Non-interventional follow-up versus fluid bolus in RESPONSE to oliguria in hemodynamically stable critically ill patients: a randomized controlled pilot trial
por: Inkinen, Nina, et al.
Publicado: (2022)

Smoking and Idiopathic Pulmonary Fibrosis
por: Oh, Chad K., et al.
Publicado: (2012)

Autophagy in Idiopathic Pulmonary Fibrosis
por: Patel, Avignat S., et al.
Publicado: (2012)

The treatment of idiopathic pulmonary fibrosis
por: Woodcock, Hannah V., et al.
Publicado: (2014)

Epidemiology of idiopathic pulmonary fibrosis
por: Ley, Brett, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ighg6oael0ok0mnp48gvrq8oeh